The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by DEAN, C. E.
* Search for Related Content
PubMed
* Articles by DEAN, C. E.
Am J Psychiatry 156:1843-1844, November 1999
© 1999 American Psychiatric Association


Letter to the Editor

Typical Neuroleptics and Increased Subcortical Volumes

CHARLES E. DEAN, M.D.
Minneapolis, Minn.

To the Editor: With regard to Raquel E. Gur, M.D., Ph.D., et al.’s (1) demonstration that higher doses of typical neuroleptics are associated with increased subcortical volumes, Nancy C. Andreasen, M.D., Ph.D., (2) wrote that 10 years ago, "no one thought that treatment could produce structural changes in the brain!" (p. 1658).

This is not the case. In 1977, Jellinger (3) reviewed the extensive literature on neuropathological changes induced by chronic neuroleptic therapy and noted that under some circumstances, neuroleptics could lead to changes that later might result in irreversible damage, especially in the caudate. As concerns over tardive dyskinesia mounted, more investigators began to pursue the association between structural brain changes, neuroleptics, and dyskinetic movements. By 1987, Waddington et al. (4) noted that eight of 11 systematic studies had found evidence of structural brain changes associated with neuroleptic-induced involuntary movements. In 1992, Dean and Borchardt (5), in a lengthy examination of the risks and the benefits of neuroleptic therapy, reviewed multiple studies performed over the previous two decades that documented ventricular enlargement, striatal atrophy, cellular degeneration, and cognitive impairment in some patients treated with neuroleptics, often in association with tardive dyskinesia.

It seems clear, then, that concerns over structural brain changes induced by neuroleptics have been present for almost three decades. There seems little doubt that such changes are in part responsible for the development of neuroleptic-induced movement disorders and cognitive impairment, although research in this area has been complicated by studies—too numerous to list here—that clearly show the presence of parkinsonism and dyskinetic movements in neuroleptic-naive patients.

Given these issues, perhaps Dr. Andreasen’s editorial comments should have included a question: Why did Dr. Gur et al. fail to include data on the prevalence and severity of abnormal movements in their cohort? Correlative data on the location, severity, and laterality of abnormal movements and anatomical changes surely would have been of great interest.

REFERENCES

  1. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC: Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998; 155:1711–1717
  2. Andreasen NC: Understanding schizophrenia: a silent spring? (editorial). Am J Psychiatry 1998; 155:1657–1659
  3. Jellinger KA: Neuropathologic findings after neuroleptic therapy, in Neurotoxicology. Edited by Roizin L, Shiraki H, Grcevic N. New York, Raven Press, 1977, pp 25–42
  4. Waddington JL, Youseff HA, Dolphin C, Kinsella A: Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia: their association in relation to the topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry 1987; 44:907–912[Abstract/Free Full Text]
  5. Dean CE, Borchardt C: Tardive dyskinesia: the risk-benefit ratio and the clinician’s dilemma. Integrative Psychiatry 1992; 8:225–235




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by DEAN, C. E.
* Search for Related Content
PubMed
* Articles by DEAN, C. E.


Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org